Product Information
LEVONEST-28 TABLET is a generic product labeled by NorthStar Rx LLC, priced at $0.3236 per EA under NDC 16714034004. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Dec 29, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
NorthStar Rx LLCNDC
16714034004
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA090719FDA Approved
12/29/2010
TE Code
AB
On Market Since
12/29/2010
Price Statistics
The NADAC for LEVONEST-28 TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 41.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3236 per EA |
|---|---|
| All-time high | $0.6002 (Feb 11, 2015) |
| All-time low | $0.2138 (Jul 17, 2024) |
| 52-week high | $0.4387 |
| 52-week low | $0.2829 |
| Median price | $0.4349 |
| Average price | $0.4344 |
| Largest weekly change | +85.8% (Nov 22, 2023) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 65% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
NorthStar Rx LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
levonorgestrel and ethinyl estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LEVONEST-28 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVONEST-28 TABLET, manufactured by NorthStar Rx LLC, is $0.3236 per EA (NDC 16714034004), effective Sep 30, 2026.
How has the price of LEVONEST-28 TABLET changed over time?
Over the history we have for it, the NADAC for LEVONEST-28 TABLET has declined 41.0%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LEVONEST-28 TABLET?
Since Nov 28, 2013, the NADAC for LEVONEST-28 TABLET has ranged from a low of $0.2138 (Jul 17, 2024) to a high of $0.6002 (Feb 11, 2015), with a median of $0.4349 per EA.
Are there cheaper alternatives to LEVONEST-28 TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEVONOR-ETH ESTRAD 0.15-0.03, is $0.1128 per EA — about 65% below LEVONEST-28 TABLET.
Who manufactures LEVONEST-28 TABLET?
LEVONEST-28 TABLET (NDC 16714034004) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.